A high-level snapshot of nutrigenomics + key predispositions across all major health systems — the ideal starting point for any client consultation. Includes highest-ranking dietary, supplement, and lifestyle recommendations (+ lifestyle data and lab marker results, if applicable).

Genetic reports covering the full range of everyday health topics. Each summary report combines dozens of the most relevant individual reports + actionable diet, supplement, and lifestyle recommendations.

Single reports zoomed in on one specific health topic — sleep quality, caffeine sensitivity, lactose tolerance, vitamin D status, anxiety, cholesterol levels, and many more. Each report drills into the specific gene variants and polygenic scores driving the predisposition, with targeted recommendations.

Unlike standard reports that aggregate risk across many genes, Pathway Reports analyze individual genes and variants in their functional context. Each report provides a detailed biochemical pathway, explains the functional impact of each variant, and delivers targeted interventions — a deep root-cause functional analysis.

These reports are modeled after the most widely-used functional genomics frameworks in integrative medicine — reimagined with 100x more genetic variants and the polygenic scoring engine. If your practice already uses any of these methodologies, our functional summaries provide a familiar structure with dramatically more analytical depth.

Single-gene deep dives — MTHFR, COMT, MAOA, and many more — covering all health areas. Each report focuses on specific gene variants, functional impact, and targeted interventions.

Targeted biohacker-focused reports — Detox, Hormone Balance, Lab Markers, Mitochondrial Health & more. These reports are more experimental and less grounded in clinical evidence. Each report drills into the specific genes and variants driving that functional system, with optimization-focused recommendations.

A clinical-grade genetic risk summary that combines the Longevity Screener, PGx, and Carrier Status. A perfect starting point for MDs and precision medicine practitioners.

Category-level disease risk reports designed for clinical decision support. Each report aggregates genetic risk across multiple related conditions, helping practitioners quickly identify which disease domains warrant closer attention.

Individual reports focused on specific conditions, covering over 150 conditions across all health areas. Each report is based on polygenic scoring driving risk for that condition, with clinically relevant guidance for prevention and monitoring.

Delivers 10-year and lifetime polygenic risk projections for 28 major chronic conditions. Based on cutting-edge genetic models trained and validated on actual medical records. A powerful tool for early intervention planning, longevity programs, and client motivation. View sample report ↗

Pharmacogenomics testing for over 50 medications across major drug classes. All guidance is aligned with CPIC and FDA pharmacogenomic recommendations — helping practitioners reduce trial-and-error and optimize medication selection and dosing. View sample report ↗

A psychiatry-focused pharmacogenomics report covering the full range of mental health medications and supplements. It's more comprehensive than standard PGx but also more experimental and less evidence-based. View sample report ↗

Screens for carrier status across 40+ inherited recessive conditions — giving practitioners the data needed to counsel clients planning families. Each condition is linked to its relevant gene, enabling precise clinical conversations and appropriate referrals. View sample report ↗

Genetic insight into personality, behavior and cognitive traits — a lighter, conversation-starter layer that complements clinical reports. Useful for client engagement and helping people connect with their genetic data on a personal level.

Genetic ancestry breakdowns covering global population groups (more recent ancestry) and maternal lineage (more distant ancestry). A useful client touchpoint that adds context to the broader genetic picture.

A flagship AI-powered whole-genome analysis that combines the most relevant findings from all other WGS reports.

Comprehensive screening for rare and ultra-rare variants across the genome that standard array-based testing can miss. The most impactful variants are shown, making the report unique for each client. Useful for clients with unexplained symptoms, complex family histories, or those who want the deepest possible look at their genetic blueprint.

Clinical-grade screening for medically actionable predisposition to serious conditions, following the ACMG SF v3.3 secondary findings guidelines. Covers genes linked to hereditary cancers, cardiovascular conditions, and metabolic disorders where early intervention can change outcomes.

An expanded pharmacogenomics analysis powered by whole-genome sequencing — covering over 500 medications. It captures structural changes like CNVs and rare variants in drug-metabolism genes that array-based PGx tests typically miss. Aligned with CPIC and FDA guidance for medication selection and dosing.